Attachment D - TANF Coaching 60 Day FRN Second Follow Up

47176

Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.676]

Announcement of Intent To Issue an
OPDIV-Initiated Supplement Under the
Standing Announcement for
Residential (Shelter) Services for
Unaccompanied Children, HHS–2017–
ACF–ORR–ZU–1132
Unaccompanied Alien
Children’s (UAC) Program, Office of
Refugee Resettlement (ORR),
Administration for Children and
Families (ACF), U.S Department of
Health and Human Services (HHS).
ACTION: Notice of intent to issue an
OPDIV-Initiated Supplement.
AGENCY:

Administration for Children
and Families, Office of Refugee
Resettlement, announces the intent to
issue an OPDIV-Initiated Supplement in
multiple installments to BCFS Health
and Human Services, San Antonio, TX.
The aggregate total of the multiple
installments will not exceed
$367,860,381. The first two installments
will be issued prior to September 30,
2018. The remaining installments will
be issued after September 30, 2018 on
to be determined dates. ORR has been
identifying additional capacity to
provide shelter for potential increases in
apprehensions of Unaccompanied
Children at the U.S. Southern Border.
Planning for increased shelter capacity
is a prudent step to ensure that ORR is
able to meet its responsibility, by law,
to provide shelter for Unaccompanied
Alien Children referred to its care by the
Department of Homeland Security
(DHS). To ensure sufficient capacity to
provide shelter to unaccompanied
children referred to HHS, BCFS
proposed to provide ORR with 3,800
beds in an expedited manner.
DATES: Supplemental award funds will
support activities through December 31,
2018.
FOR FURTHER INFORMATION CONTACT:
Jallyn Sualog, Director, Division of
Children’s Services, Office of Refugee
Resettlement, 330 C Street SW,
Washington, DC 20447. Phone: 202–
401–4997. Email: DCSProgram@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: ORR is
continuously monitoring its capacity to
shelter the unaccompanied children
referred to HHS, as well as the
information received from interagency
partners, to inform any future decisions
or actions.

daltland on DSKBBV9HB2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

19:14 Sep 17, 2018

Jkt 244001

ORR has specific requirements for the
provision of services. Award recipients
must have the infrastructure, licensing,
experience, and appropriate level of
trained staff to meet those requirements.
The expansion of the existing program
and its services through this
supplemental award is a key strategy for
ORR to be prepared to meet its
responsibility to provide shelter for
Unaccompanied Children referred to its
care by DHS and so that the U.S. Border
Patrol can continue its vital national
security mission to prevent illegal
migration, trafficking, and protect the
borders of the United States.
Statutory Authority: This program is
authorized by—
(A) Section 462 of the Homeland
Security Act of 2002, which in March
2003, transferred responsibility for the
care and custody of Unaccompanied
Alien Children from the Commissioner
of the former Immigration and
Naturalization Service (INS) to the
Director of ORR of the Department of
Health and Human Services (HHS).
(B) The Flores Settlement Agreement,
Case No. CV85–4544RJK (C.D. Cal.
1996), as well as the William
Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008
(Pub. L. 110–457), which authorizes
post release services under certain
conditions to eligible children. All
programs must comply with the Flores
Settlement Agreement, Case No. CV85–
4544–RJK (C.D. Cal. 1996), pertinent
regulations and ORR policies and
procedures.
Karen Shields,
Grants Policy Specialist, Division of Grants
Policy, Office of Administration.
[FR Doc. 2018–20295 Filed 9–14–18; 11:15 am]
BILLING CODE 4184–45–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity
Office of Planning, Research,
and Evaluation; ACF; HHS.
ACTION: Request for public comment.
AGENCY:

Title: Evaluation of Employment
Coaching for TANF and Related
Populations—Second Follow-Up Survey
(OMB #0970–0506).
SUMMARY: The Administration for
Children and Families (ACF) is
proposing an additional data collection
activity as part of the Evaluation of

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

Employment Coaching for TANF and
Related Populations. The Office of
Management and Budget (OMB) Office
of Information and Regulatory Affairs
approved this information collection in
March 2018 (0970–0506). ACF is
proposing a second follow-up survey
conducted as part of the evaluation.
This study will provide an
opportunity to learn more about the
potential of coaching to help clients
achieve self-sufficiency and other
desired employment-related outcomes.
It will take place over five years in the
following employment programs:
MyGoals for Employment Success in
Baltimore, MyGoals for Employment
Success in Houston, Family
Development and Self-Sufficiency
program in Iowa, LIFT in New York
City, Chicago, and Los Angeles; Work
Success in Utah; and Goal4 It! in
Jefferson County, Colorado. Together,
these programs will include Temporary
Assistance for Needy Families (TANF)
agencies and other public or private
employment programs that serve lowincome individuals. Each site will have
a robust coaching component and the
capacity to conduct a rigorous impact
evaluation. This study will provide
information on whether coaching helps
people obtain and retain jobs, advance
in their careers, move toward selfsufficiency, and improve their overall
well-being. To meet these objectives,
this study includes an impact and
implementation study, as approved by
OMB.
This submission builds on the
existing impact study, which randomly
assigned participants to either a
‘‘program group,’’ who were paired with
a coach, or to a ‘‘control group,’’ who
were not paired with a coach. The
effectiveness of the coaching will be
determined by differences between
members of the program and control
groups in outcomes such as obtaining
and retaining employment, earnings,
measures of self-sufficiency, and
measures of self-regulation.
The proposed information collection
activity is a second follow-up survey,
which will be available to participants
approximately 21 months after random
assignment. The second follow-up
survey will provide rigorous evidence
on whether the coaching interventions
are effective, for whom, and under what
circumstances.
Respondents: Individuals enrolled in
the Evaluation of Employment Coaching
for TANF and Related Populations. All
participants will be able to opt out of
participating in the data collection
activities.

E:\FR\FM\18SEN1.SGM

18SEN1

Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices

47177

ANNUAL BURDEN ESTIMATES
Instrument

Total number
of respondents

Annual
number of
respondents

Number of
responses per
respondent

Average
burden hours
per response

Annual burden
hours

Second follow-up survey ......................................................

4,800

1,600

1

1

1,600

Estimated Total Annual Burden
Hours: 1,600.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
the Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.

Food and Drug Administration

DATES:

Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. Email
address: OPREinfocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.

ADDRESSES:

The
Department specifically requests
comments on (a) whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.

SUPPLEMENTARY INFORMATION:

daltland on DSKBBV9HB2PROD with NOTICES

Authority: Section 413 of the Social
Security Act, as amended by the FY 2017
Consolidated Appropriations Act, 2017 (Pub.
L. 115–31).
Emily B. Jabbour,
ACF/OPRE Certifying Officer.
[FR Doc. 2018–20223 Filed 9–17–18; 8:45 am]
BILLING CODE 4184–09–P

VerDate Sep<11>2014

19:14 Sep 17, 2018

Jkt 244001

[Docket No. FDA–2017–N–7022]

Post-Marketing Pediatric-Focused
Product Safety Reviews;
Establishment of a Public Docket;
Request for Comments
AGENCY:

Food and Drug Administration,

HHS.
Notice; establishment of a
public docket; request for comments.

ACTION:

The Food and Drug
Administration (FDA) has established a
public docket to collect comments
related to the post-marketing, pediatricfocused safety reviews of products
posted between April 2, 2018, and
September 14, 2018, on FDA’s website
but not presented at the September 20,
2018, Pediatric Advisory Committee
(PAC) meeting. These reviews are
intended to be available for review and
comment by members of the PAC,
interested parties (such as academic
researchers, regulated industries,
consortia, and patient groups), and the
general public.

SUMMARY:

Submit either electronic or
written comments by September 28,
2018.

DATES:

FDA has established a
docket for public comment on this
document. The docket number is FDA–
2017–N–7022. The docket will close on
September 28, 2018. Submit either
electronic or written comments by that
date. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before September 28, 2018. The
https://www.regulations.gov electronic
filing system will accept comments
until midnight Eastern Time at the end
of September 28, 2018. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
You may submit comments as
follows:

ADDRESSES:

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to make available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–N–7022 for ‘‘Post-Marketing
Pediatric-Focused Product Safety
Reviews; Establishment of a Public
Docket; Request for Comments.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9

E:\FR\FM\18SEN1.SGM

18SEN1